Classic/Amiopathic dermatomyositis;Dermatomiosite clássica/amiopática

Acta Medica Portuguesa

Volumn 13, Issue 5-6, 2000, Pages 287-294

  Vilas, Ana Paula ^a   Fiúza, Teresa ^a  

^a HOSPITAL PULIDO VALENTE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; CYCLOPHOSPHAMIDE; CYCLOSPORIN; PREDNISONE;

CANCER RISK; CLINICAL FEATURE; DERMATOMYOSITIS; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; HUMAN; PATHOGENESIS; PROGNOSIS; REVIEW;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; CREATINE KINASE; DERMATOMYOSITIS; ELECTROMYOGRAPHY; HUMANS; PARANEOPLASTIC SYNDROMES; PROGNOSIS; SKIN;

EID: 0342903190     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. DALAKAS MC: Clinical, immunopathologic, and therapeutic considerations of inflamatory myopathies. Clin Neuropharm 1992; 15 (5): 327-351
2. DALAKAS MC: Polymyositis, dermatomyosistis, and inclusion-body myositis. N Eng J Med 1991; 325 (21): 1487-1498
3. GREVELINK S, MOSCHELLA SL, KAY J: Dermatomyositis update. J Clin Rheumatol 1995; 1 (1): 2-12
4. PLOTZ, PH, DALAKASM, LEFF RL, LOVE LA, MILLER FW, CROWN ME: Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis and related disorders. Ann Intern Med 1989: 111: 143-157
5. TYMMS KE, WEBB J: Dermapolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol 1985; 12: 1140-1148
6. PEARSON CM, BOHAN A: The spectrum of polymyositis and dermatomyositis. Med Clin North Am 1977; 61 (2): 439-457
7. HIDANO A, KANEKO K, ARAI Y, KIKUCHI R: Survey of the prognosis for dermatomyositis, with special reference to its association with malignancy and pulmonary fibrosis. J Dermatol 1986; 13: 233-241
8. BENBASSET J, GEFEL D, LARHOLT K, SUKENIK S, MORGENSTERN V, ZLOTNICK A: Prognostic factors in polymiositis/dermatomyositis: a computer-assisted analysis of 92 cases. Arthritis Rheum 1985; 28 (3):249-255
9. SIGURGIERSSON B, LINDELOF B, EDHAG O, ALLANDER E: Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Eng J Med 1992; 326 (6):363-367
10. BARNES BE: Dermatomyositis and malignancy: a review of the literature. Ann Intern Med 1976; 84: 68-76
11. EMSLIE-SMITH AM, ENGEL AG: Microvascular changes in early and advanced dermatomyositis: a quantative study. Ann Neurol 1990; 27: 343-356
12. KISSEL JT, MENDELL JR, KOTTIL W, RAMMOHAN KW: Microvascular deposition of complement membrane attack complex in dermatomyositis. N Eng J Med 1986; 314 (6): 329-334
13. CALLEN JP: Dermatomiosite - uma actualização sobre o diagnóstico, avaliação e tratamento. Med Cir 1995; 7/8: 140-146
14. COSNES A, AMAUDRIC F, GHERARDI R, et al: Dermatomyositis without muscle weakness: Long-term foolow-up of 12 patients without systemic corticosteroids. Arch Dermatol 1995; 131:1381-1385
15. EUWER RL, SONTHEIMER RD: Amyopathic dermatomyositis (dermatomyositis siné miositis). J Am Acad Dermatol 1991; 24: 959-966
16. BOHAN A, PETER JB: Polymyositis and dermatomyositis. N Eng J Med 1975; 292: 344-347; 403-407
17. BUNCH TW: Polymyositis: a case history approach to the differencial diagnosis and treatment.. Mayo Clin Proc 1990; 65: 1480-1497
18. ROCKERBIE NR, WOO T, CALLEN JP, GIUSTINA T: Cutaneous changes of dermatomyositis precede muscle weakness. J Am Acad Dermatol 1989; 20: 629-632
19. KAGEN LJ, ARAM S: Creatine kinase activity inhibitor in sera from patients with muscle disease. Arthritis Rheum 1987; 30 (2): 213-217
20. KAGEN LJ: Myoglobinemia in inflammatory myopathies. JAMA 1977; 237: 1448-1452
21. POLK JR, KAGEN LJ: Polymyositis and dermatomyositis. In Paget S, Beary III JF, eds. Manual of rheumatology and outpatient orthopedic disorders: Little, Brown and Company, 1993
22. TARGOFF IN, ARNETT FC: Clinical manifestations in patients with antibody to PL-12 antigen /alanyl-tRNA syntetase). Am J Med 1990; 88: 241-251
23. PARK JH, OLSE NJ, KING et al: Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle disfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum 1995; 38: 68-77
24. GUILLET G, GUILLET J, SANCIAUME C, MALEVILLE J, GENIAUX M, MORIN P: Evaluation of muscular lesions in connective tissue diseases: Tallium 201 muscular scans. J Am Acad Dermatol 1988; 18: 663-666
25. DALAKAS MC, ILLA I, DAMBROSIA JM et al: A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Eng J Med 1993; 329 (27): 1993-2000
26. CHERIN P, HERSON S, WECHSLER B et al: intravenous immunoglobulin for polymyositis and dermatomyositis. Lancet 1990: 116
27. BONNETBLANC JM, BERNARD P, FAYOL J: Dermatomyositis and malignancy: a multicenter cooperative study. Dermatologica 1990: 180: 212-216
28. PONGE A, MUSSINI JM, PONGE T, MAUGARS Y, COTTIN S: Dermatoplymyosites paranéoplasiques. Rev Méd Interne 1987: 8: 251-256
29. BASSET-SEGUIN N, ROUJEAU JC, GHERARDI R, GUILLAUME, JC, REVUS J, TOURAINE R: Prognostic factors and predictive signs of malignancy in adult dermatomyositis: a study of 32 cases. Arch Dermatol 1990; 126: 633-637
30. VESTERAGER L, WORM AM, THOMSEN K: Dermatomyositis and malignancy. Clin Exp Dermatol 1980: 5: 31-35
31. CHOW WH, GRIDLEY G, MELLEMKJAER L, MCLAUGHLIN JK, OLSEN JH, FRAUMENI JR JF: Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control 1995; 6: 9-13
32. WHITMORE SE, ROSENSHEIN NB, PROVOST TT: Ovarian cancer in patients with dermatomyositis. Medicine 1994; 73: 153-160
33. CHERIN P, PIETTE JC, HERSON S et al: Dermatomyositis and ovarian cancer: a report of 7 cases and literature review. J Rheumatol 1993; 20: 1897-1899
34. SCERRI L, ZAKI I, ALLEN BR, GOLDING P: Dermatomyositis associated with malignancy melanoma- case report and review of the literature. Clin Exp Dermatol 1994; 19: 523-525